A detailed history of Tom Gayner (Markel Corp) transactions in Novo Nordisk A S stock. As of the latest transaction made, Markel Corp holds 2,150,000 shares of NVO stock, worth $183 Million. This represents 2.49% of its overall portfolio holdings.

Number of Shares
2,150,000
Previous 2,150,000 -0.0%
Holding current value
$183 Million
Previous $307 Million 16.58%
% of portfolio
2.49%
Previous 3.22%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 03, 2023

BUY
$90.94 - $199.54 $97.8 Million - $215 Million
1,075,000 Added 100.0%
2,150,000 $196 Million
Q3 2017

Oct 27, 2017

BUY
$41.15 - $49.22 $44.2 Million - $52.9 Million
1,075,000
1,075,000 $51.8 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track Tom Gayner's Portfolio

Track Tom Gayner Portfolio

Follow Tom Gayner (Markel Corp) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Markel Corp, based on Form 13F filings with the SEC.

News

Stay updated on Markel Corp and Tom Gayner with notifications on news.